Loading...

Mallory Loflin

Title(s)Assistant Adjunct Professor, Psychiatry
SchoolHealth Sciences
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Farmer S, Slavin MN, Loflin MJE, Luba R, Earleywine M. Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis. J Psychoactive Drugs. 2019 Jul 29; 1-8. PMID: 31352867.
      View in: PubMed
    2. Loflin MJE, Babson K, Sottile J, Norman SB, Gruber S, Bonn-Miller MO. A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis. Am J Drug Alcohol Abuse. 2019 May 28; 1-8. PMID: 31135227.
      View in: PubMed
    3. Meffert BN, Morabito DM, Mosich MK, Loflin MJ, Sottile J, Heinz AJ. Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis. Curr Drug Res Rev. 2019; 11(1):3-11. PMID: 30793115.
      View in: PubMed
    4. Bonn-Miller MO, ElSohly MA, Loflin MJE, Chandra S, Vandrey R. Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches. Int Rev Psychiatry. 2018 06; 30(3):277-284. PMID: 30179534.
      View in: PubMed
    5. Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017 Nov 07; 318(17):1708-1709. PMID: 29114823.
      View in: PubMed
    6. Loflin M, Babson K, Browne K, Bonn-Miller M. Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):19-23. PMID: 29058471.
      View in: PubMed
    7. Loflin MJE, Earleywine M, Farmer S, Slavin M, Luba R, Bonn-Miller M. Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay. J Psychoactive Drugs. 2017 Nov-Dec; 49(5):393-397. PMID: 28771093.
      View in: PubMed
    8. Loflin M, Earleywine M, Bonn-Miller M. Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD. Addict Behav. 2017 05; 68:18-23. PMID: 28088054.
      View in: PubMed
    9. Loflin MJ, Babson KA, Bonn-Miller MO. Cannabinoids as therapeutic for PTSD. Curr Opin Psychol. 2017 Apr; 14:78-83. PMID: 28813324.
      View in: PubMed
    10. Loflin M, Earleywine M. The case for medical marijuana: an issue of relief. Drug Alcohol Depend. 2015 Apr 01; 149:293-7. PMID: 25941693.
      View in: PubMed
    11. Loflin M, Earleywine M. No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. Can J Respir Ther. 2015; 51(1):7-9. PMID: 26078621.
      View in: PubMed
    12. Loflin M, Earleywine M. A new method of cannabis ingestion: the dangers of dabs? Addict Behav. 2014 Oct; 39(10):1430-3. PMID: 24930049.
      View in: PubMed
    13. Loflin M, Earleywine M, De Leo J, Hobkirk A. Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use. Subst Use Misuse. 2014 Mar; 49(4):427-34. PMID: 24093525.
      View in: PubMed
    Mallory's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Similar People
    People who share similar concepts with this person.
    _
    Same Department